Dario Kohlbrenner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dario Kohlbrenner has a total of 159 co-authors. Here are the top co-authors by number of shared publications:
- Christian F. Clarenbach
Faculty of Medicine, University of Zurich, Zurich, Switzerland
17 shared publications - Noriane Andrina Sievi
Department of Pulmonology University Hospital Zurich Zurich Switzerland
10 shared publications - Manuel Kuhn
Faculty of Medicine, University of Zurich, Zurich, Switzerland
8 shared publications - Christoph Gross
Department of Management, Technology, and Economics, ETH Zürich, Zürich, Switzerland
7 shared publications - Adam Ivankay
IBM Research - Europe, Zurich, Switzerland
6 shared publications - Thomas Brunschwiler
IBM Research Europe, Zurich, Switzerland
6 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Springer Nature in Sports Medicine
- Vol. 56 (11) , 2767-2782
The Effects of Intermittent Hypoxic Training Strategies on Maximal Oxygen Uptake in Healthy Humans: A Meta-analysis with Meta-regression
Background: Intermittent hypoxic training aims to enhance exercise performance and health, commonly assessed through maximal oxygen uptake ( V O 2 max). Currently applied methods are live-high train-low (LHTL), live-low train-high (LLTH) and passive hypoxic conditioning (PHC). However, within these methods, numerous modes of application exist, and effectiveness is debated. Objective: To determine the effect of LHTL, LLTH and PHC on V O 2 max in healthy participants, and identify factors associated with the amplitude of change in V O 2 max. Methods: We conducted a systematic review with random-effects meta-analysis and meta-regression. Studies were identified through PubMed, EMBASE and Web of Science. We included controlled studies, calculating between-group standardised mean differences. Athlete and non-athlete populations were analysed separately. RoB2 was used to assess study quality and publication bias was investigated with funnel plots and the Egger’s test. Results: Of the 5244 identified studies, 62 were included for analysis, resulting in a sample size of 1332 participants (610 athletes, 722 non-athletes). LHTL increased V O 2 max significantly more than control in athletes (mean difference [MD] = 2.17; 95% CI = 0.77, 3.56) but not in non-athletes (MD = 3.1; 95% CI = − 0.23, 6.43). LLTH did not increase V O 2 max significantly more than control in athletes (MD = 0.89; 95% CI = − 0.27, 2.05) but it did in non-athletes (MD = 1.70; 95% CI = 0.85, 2.54). PHC did not increase V O 2 max significantly more than control in athletes (MD = − 1.07; 95% CI = − 3.51, 1.37) but it did in non-athletes (MD = 2.26; 95% CI = 1.00, 3.52). Multivariate meta-regressions identified the severity, duration, and frequency of hypoxic exposure to be significantly associated with the change in V O 2 max. Conclusions: LHTL showed a significant effect on V O 2 max in athletic populations while LLTH and PHC showed a significant effect on V O 2 max in non-athletic populations only. Future studies should target investigating which characteristics (e.g. severity, duration) of the hypoxic exposure are most beneficial.
- 15 September 2026
- Published by Springer Nature in Sports Medicine
- Vol. 56 (11) , 2767-2782
Open AccessThe Effects of Intermittent Hypoxic Training Strategies on Maximal Oxygen Uptake in Healthy Humans: A Meta-analysis with Meta-regression
Background: Intermittent hypoxic training aims to enhance exercise performance and health, commonly assessed through maximal oxygen uptake ( V O 2 max). Currently applied methods are live-high train-low (LHTL), live-low train-high (LLTH) and passive hypoxic conditioning (PHC). However, within these methods, numerous modes of application exist, and effectiveness is debated. Objective: To determine the effect of LHTL, LLTH and PHC on V O 2 max in healthy participants, and identify factors associated with the amplitude of change in V O 2 max. Methods: We conducted a systematic review with random-effects meta-analysis and meta-regression. Studies were identified through PubMed, EMBASE and Web of Science. We included controlled studies, calculating between-group standardised mean differences. Athlete and non-athlete populations were analysed separately. RoB2 was used to assess study quality and publication bias was investigated with funnel plots and the Egger’s test. Results: Of the 5244 identified studies, 62 were included for analysis, resulting in a sample size of 1332 participants (610 athletes, 722 non-athletes). LHTL increased V O 2 max significantly more than control in athletes (mean difference [MD] = 2.17; 95% CI = 0.77, 3.56) but not in non-athletes (MD = 3.1; 95% CI = − 0.23, 6.43). LLTH did not increase V O 2 max significantly more than control in athletes (MD = 0.89; 95% CI = − 0.27, 2.05) but it did in non-athletes (MD = 1.70; 95% CI = 0.85, 2.54). PHC did not increase V O 2 max significantly more than control in athletes (MD = − 1.07; 95% CI = − 3.51, 1.37) but it did in non-athletes (MD = 2.26; 95% CI = 1.00, 3.52). Multivariate meta-regressions identified the severity, duration, and frequency of hypoxic exposure to be significantly associated with the change in V O 2 max. Conclusions: LHTL showed a significant effect on V O 2 max in athletic populations while LLTH and PHC showed a significant effect on V O 2 max in non-athletic populations only. Future studies should target investigating which characteristics (e.g. severity, duration) of the hypoxic exposure are most beneficial.
- Open Access
Acute cardiorespiratory responses to low-load blood-flow restriction vs high-load resistance exercise in COPD: a randomised crossover trial
Introduction: Dyspnoea is a major barrier to effective pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD). Low-load blood flow restriction (LL-BFR) resistance exercise may reduce ventilatory demand and dyspnoea burden compared with traditional high-load resistance exercise (HL-TRA). However, its acute physiological and perceptual effects in COPD remain unclear. We compared the acute physiological and perceptual responses to LL-BFR and HL-TRA in patients with COPD. Methods: In a randomised crossover trial, 24 patients with moderate to severe COPD performed LL-BFR (30% of one-repetition maximum (1RM); four sets separated by three rest periods) and HL-TRA (70% of 1RM; three sets separated by two rest periods). Ventilation (V̇E), tidal volume (VT), oxygen uptake (V̇O₂), carbon dioxide output (V̇CO₂), heart rate and ratings of perceived exertion (RPE) were measured throughout. Linear mixed models with participant-level random intercepts were used to compare responses between conditions. Results: LL-BFR resulted in lower V̇E (−2.2 L/min), VT (−0.08 L), V̇O₂ (−0.04 L/min) and V̇CO₂ (−0.07 L/min) compared with HL-TRA. Heart rate and breathing rate were similar across both conditions. Dyspnoea was significantly reduced (RPE −0.7), while leg effort increased (RPE +0.7). LL-BFR was well tolerated, with no adverse events. Discussion: Compared with HL-TRA, LL-BFR was associated with lower ventilatory and metabolic demands and lower perceived dyspnoea despite higher perceived leg exertion. These findings suggest that LL-BFR may represent a useful resistance training strategy for patients with COPD who are primarily limited by dyspnoea during exercise. Trial registration number: NCT05163600 .
Open AccessAcute cardiorespiratory responses to low-load blood-flow restriction vs high-load resistance exercise in COPD: a randomised crossover trial
Introduction: Dyspnoea is a major barrier to effective pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD). Low-load blood flow restriction (LL-BFR) resistance exercise may reduce ventilatory demand and dyspnoea burden compared with traditional high-load resistance exercise (HL-TRA). However, its acute physiological and perceptual effects in COPD remain unclear. We compared the acute physiological and perceptual responses to LL-BFR and HL-TRA in patients with COPD. Methods: In a randomised crossover trial, 24 patients with moderate to severe COPD performed LL-BFR (30% of one-repetition maximum (1RM); four sets separated by three rest periods) and HL-TRA (70% of 1RM; three sets separated by two rest periods). Ventilation (V̇E), tidal volume (VT), oxygen uptake (V̇O₂), carbon dioxide output (V̇CO₂), heart rate and ratings of perceived exertion (RPE) were measured throughout. Linear mixed models with participant-level random intercepts were used to compare responses between conditions. Results: LL-BFR resulted in lower V̇E (−2.2 L/min), VT (−0.08 L), V̇O₂ (−0.04 L/min) and V̇CO₂ (−0.07 L/min) compared with HL-TRA. Heart rate and breathing rate were similar across both conditions. Dyspnoea was significantly reduced (RPE −0.7), while leg effort increased (RPE +0.7). LL-BFR was well tolerated, with no adverse events. Discussion: Compared with HL-TRA, LL-BFR was associated with lower ventilatory and metabolic demands and lower perceived dyspnoea despite higher perceived leg exertion. These findings suggest that LL-BFR may represent a useful resistance training strategy for patients with COPD who are primarily limited by dyspnoea during exercise. Trial registration number: NCT05163600 .
- Open Access
- 16 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e88325
Implementing Digital Respiratory Technologies for People With Respiratory Conditions: Scoping Review
Background: Digital health offers opportunities for safe, equitable, and accessible care, and its integration into respiratory care is a strategic priority for the European Respiratory Society. However, sustainable implementation remains complex, and guidance for health care systems is limited. Objective: This study aimed to undertake a scoping review of the published initiatives that have implemented digital respiratory technologies into real-world routine clinical practice over the past decade, identify the technologies used, implementation strategies used, the challenges and supports they encountered, and the lessons they reported for making care more equitable, strengthening patient-professional relationships, improving the patient journey, and reducing environmental impact. Methods: Following Arksey and O’Malley’s methodology, we searched ten databases (December 2013‐2023 [updated April 2025 and February 2026]): MEDLINE, Embase, CINAHL, PsycINFO, Cochrane Library, Web of Science, Scopus, IEEE Xplore, CABI Global Health, and WHO Medicus; and used key domains in the commonly used implementation frameworks such as the Consolidated Framework for Implementation Research (CFIR), Nonadaptation, Abandonment, and Challenges to the Scale-up, Spread, and Sustainability of Health and Care Technologies (NASSS), and the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework to categorize results and understand methodologies used. As a scoping review, we mapped the available evidence, rather than synthesizing outcomes, appraising study quality, or estimating effectiveness. To broaden coverage and strengthen interpretation, we crowdsourced additional studies and sought feedback on our preliminary findings from a network of respiratory experts across 17 countries. Results: Overall, 24,672 studies were identified; after deduplication, 14,811 were screened; 84 studies from 31 countries were included in the final review. The digital respiratory technologies comprised apps, platforms, chatbots, and smart devices. Reported technological functionalities encompassed remote consultation, clinician monitoring, video directly observed therapy, remote rehabilitation training, self-management support, education, monitoring medication adherence, and a school-based remote clinic. CFIR, RE-AIM, and the plan-do-study-act (PDSA) cycle were the most widely used frameworks. Successful implementation used simple technologies that fitted existing workflows and avoided additional workload. Co-development and trust-building with end-users influenced motivation and adoption, while leadership, team cohesion, and communication facilitated success. Barriers included insufficient resources, poor interoperability, lack of funding and reimbursement, and limited technical support. Conclusions: This scoping review provides a cross-condition review of digital respiratory technologies implemented in routine clinical practice. Unlike previous disease-specific or experimental-focused reviews, our innovative approach used established implementation Theories, Models, and Frameworks (TMFs) to identify shared barriers and enablers across diverse populations and health care systems. We summarize key implementation domains in state-of-the-art digital respiratory care and identify major gaps related to health equity, patient–clinician trust, continuity of support, and environmental sustainability. These findings emphasize the value of using implementation TMFs for scaling effective, patient-centered digital respiratory care in real-world settings.
- 16 June 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e88325
Open AccessImplementing Digital Respiratory Technologies for People With Respiratory Conditions: Scoping Review
Background: Digital health offers opportunities for safe, equitable, and accessible care, and its integration into respiratory care is a strategic priority for the European Respiratory Society. However, sustainable implementation remains complex, and guidance for health care systems is limited. Objective: This study aimed to undertake a scoping review of the published initiatives that have implemented digital respiratory technologies into real-world routine clinical practice over the past decade, identify the technologies used, implementation strategies used, the challenges and supports they encountered, and the lessons they reported for making care more equitable, strengthening patient-professional relationships, improving the patient journey, and reducing environmental impact. Methods: Following Arksey and O’Malley’s methodology, we searched ten databases (December 2013‐2023 [updated April 2025 and February 2026]): MEDLINE, Embase, CINAHL, PsycINFO, Cochrane Library, Web of Science, Scopus, IEEE Xplore, CABI Global Health, and WHO Medicus; and used key domains in the commonly used implementation frameworks such as the Consolidated Framework for Implementation Research (CFIR), Nonadaptation, Abandonment, and Challenges to the Scale-up, Spread, and Sustainability of Health and Care Technologies (NASSS), and the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework to categorize results and understand methodologies used. As a scoping review, we mapped the available evidence, rather than synthesizing outcomes, appraising study quality, or estimating effectiveness. To broaden coverage and strengthen interpretation, we crowdsourced additional studies and sought feedback on our preliminary findings from a network of respiratory experts across 17 countries. Results: Overall, 24,672 studies were identified; after deduplication, 14,811 were screened; 84 studies from 31 countries were included in the final review. The digital respiratory technologies comprised apps, platforms, chatbots, and smart devices. Reported technological functionalities encompassed remote consultation, clinician monitoring, video directly observed therapy, remote rehabilitation training, self-management support, education, monitoring medication adherence, and a school-based remote clinic. CFIR, RE-AIM, and the plan-do-study-act (PDSA) cycle were the most widely used frameworks. Successful implementation used simple technologies that fitted existing workflows and avoided additional workload. Co-development and trust-building with end-users influenced motivation and adoption, while leadership, team cohesion, and communication facilitated success. Barriers included insufficient resources, poor interoperability, lack of funding and reimbursement, and limited technical support. Conclusions: This scoping review provides a cross-condition review of digital respiratory technologies implemented in routine clinical practice. Unlike previous disease-specific or experimental-focused reviews, our innovative approach used established implementation Theories, Models, and Frameworks (TMFs) to identify shared barriers and enablers across diverse populations and health care systems. We summarize key implementation domains in state-of-the-art digital respiratory care and identify major gaps related to health equity, patient–clinician trust, continuity of support, and environmental sustainability. These findings emphasize the value of using implementation TMFs for scaling effective, patient-centered digital respiratory care in real-world settings.
- Open Access
- 2 April 2026
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 342, 104568
Corrigendum to “Characterisation of acute hypoxic response using breath variability parameters: A pilot study” [Respir. Physiol. Neurobiol. 315 (2023) 104096]
- 2 April 2026
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 342, 104568
Open AccessCorrigendum to “Characterisation of acute hypoxic response using breath variability parameters: A pilot study” [Respir. Physiol. Neurobiol. 315 (2023) 104096]
- 1 November 2025
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 329 (5) , R805-R812
Moderate intermittent hypoxic conditioning to enhance cerebrovascular function in the elderly: a randomized controlled trial
This study is the first to investigate the effects of IHC on CVR CO2 over the short- and mid-term in elderly individuals. Contrary to our initial hypothesis, 8 wk of moderate IHC did not enhance CVR CO2 at any time point.
- 1 November 2025
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 329 (5) , R805-R812
Moderate intermittent hypoxic conditioning to enhance cerebrovascular function in the elderly: a randomized controlled trial
This study is the first to investigate the effects of IHC on CVR CO2 over the short- and mid-term in elderly individuals. Contrary to our initial hypothesis, 8 wk of moderate IHC did not enhance CVR CO2 at any time point.
- Open Access
- 27 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0314914
Implementing digital respiratory technologies for people with respiratory conditions: A protocol for a scoping review
The value of ‘data-enabled’, digital healthcare is evolving rapidly, as demonstrated in the COVID-19 pandemic, and its successful implementation remains complex and challenging. Harmonisation (within/between healthcare systems) of infrastructure and implementation strategies has the potential to promote safe, equitable and accessible digital healthcare, but guidance for implementation is lacking. Using respiratory technologies as an example, our scoping review process will capture and review the published research between 12th December 2013 to 12th December 2023. Following standard methodology (Arksey and O’Malley), we will search for studies published in ten databases: MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane Library, Web of Science, Scopus, IEEE Xplore, CABI Global Health, and WHO Medicus. Our search strategy will use the terms: digital health, respiratory conditions, and implementation. Using Covidence, screening of abstracts and full texts will be undertaken by two independent reviewers, with conflicts resolved by a third reviewer. Data will be extracted into a pilot-tested data extraction table for charting, summarising and reporting the results. We will conduct stakeholder meetings throughout to discuss the themes emerging from implementation studies and support interpretation of findings in the light of their experience within their own networks and organisations. The findings will inform the future work within the ERS CONNECT clinical research collaboration and contribute to policy statements to promote a harmonised framework for digital transformation of respiratory healthcare.
- 27 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (12) , e0314914
Open AccessImplementing digital respiratory technologies for people with respiratory conditions: A protocol for a scoping review
The value of ‘data-enabled’, digital healthcare is evolving rapidly, as demonstrated in the COVID-19 pandemic, and its successful implementation remains complex and challenging. Harmonisation (within/between healthcare systems) of infrastructure and implementation strategies has the potential to promote safe, equitable and accessible digital healthcare, but guidance for implementation is lacking. Using respiratory technologies as an example, our scoping review process will capture and review the published research between 12th December 2013 to 12th December 2023. Following standard methodology (Arksey and O’Malley), we will search for studies published in ten databases: MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane Library, Web of Science, Scopus, IEEE Xplore, CABI Global Health, and WHO Medicus. Our search strategy will use the terms: digital health, respiratory conditions, and implementation. Using Covidence, screening of abstracts and full texts will be undertaken by two independent reviewers, with conflicts resolved by a third reviewer. Data will be extracted into a pilot-tested data extraction table for charting, summarising and reporting the results. We will conduct stakeholder meetings throughout to discuss the themes emerging from implementation studies and support interpretation of findings in the light of their experience within their own networks and organisations. The findings will inform the future work within the ERS CONNECT clinical research collaboration and contribute to policy statements to promote a harmonised framework for digital transformation of respiratory healthcare.
- Open Access
- 1 December 2024
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 19, 2739-2750
Hybrid Virtual Coaching and Telemonitoring in COPD Management: The CAir Randomised Controlled Study
Objective: To investigate the effectiveness of 12-weeks hybrid virtual coaching on health-related quality-of-life (HrQoL) in patients with stable COPD. Methods: We equipped all patients with a CAir Desk for telemonitoring, the intervention group additionally received hybrid virtual coaching through the built-in smartphone. The multimodal intervention based on the Living well with COPD programme, containing educational content, physical activity coaching, and home-based exercises. Primary outcome was HrQoL as measured by the SGRQ. Secondary outcomes were symptom burden, physical activity, functional exercise capacity, and lung function. Between-group differences were calculated using linear regression models, controlling for baseline differences. Results: We included 30 participants with COPD (13/17 women/men; 63 [9] years; FEV1 54 [22] % predicted), 24 (80%) completed the study. SGRQ improved in both groups (intervention: − 4.5 [20.1]; control: − 2.7 [7.4] points) without statistically significant or clinically relevant between-group differences (B = − 2.5 points, 95% CI = − 24.3, 19.3, p = 0.81). Physical activity increased only in the intervention group (313 [1561] vs − 364 [2399] steps) without statistically significant but clinically relevant between-group difference (B = 2147 steps, 95% CI = − 86, 4395, p = 0.06). Symptom burden decreased in both groups (− 4.2 [6.7] vs − 1.0 [2.8] points) without statistically significant but clinically relevant between-group difference (B = − 3.0 points, 95% CI = − 10.8, 5.0, p = 0.43). Conclusion: Twelve-weeks hybrid virtual coaching did not improve HrQoL more than telemonitoring only in patients with stable COPD. The intervention group improved their physical activity and symptom burden clinically relevant more than the control group.
- 1 December 2024
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 19, 2739-2750
Open AccessHybrid Virtual Coaching and Telemonitoring in COPD Management: The CAir Randomised Controlled Study
Objective: To investigate the effectiveness of 12-weeks hybrid virtual coaching on health-related quality-of-life (HrQoL) in patients with stable COPD. Methods: We equipped all patients with a CAir Desk for telemonitoring, the intervention group additionally received hybrid virtual coaching through the built-in smartphone. The multimodal intervention based on the Living well with COPD programme, containing educational content, physical activity coaching, and home-based exercises. Primary outcome was HrQoL as measured by the SGRQ. Secondary outcomes were symptom burden, physical activity, functional exercise capacity, and lung function. Between-group differences were calculated using linear regression models, controlling for baseline differences. Results: We included 30 participants with COPD (13/17 women/men; 63 [9] years; FEV1 54 [22] % predicted), 24 (80%) completed the study. SGRQ improved in both groups (intervention: − 4.5 [20.1]; control: − 2.7 [7.4] points) without statistically significant or clinically relevant between-group differences (B = − 2.5 points, 95% CI = − 24.3, 19.3, p = 0.81). Physical activity increased only in the intervention group (313 [1561] vs − 364 [2399] steps) without statistically significant but clinically relevant between-group difference (B = 2147 steps, 95% CI = − 86, 4395, p = 0.06). Symptom burden decreased in both groups (− 4.2 [6.7] vs − 1.0 [2.8] points) without statistically significant but clinically relevant between-group difference (B = − 3.0 points, 95% CI = − 10.8, 5.0, p = 0.43). Conclusion: Twelve-weeks hybrid virtual coaching did not improve HrQoL more than telemonitoring only in patients with stable COPD. The intervention group improved their physical activity and symptom burden clinically relevant more than the control group.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA526
The effect of blood-flow restricted strength and sprint training on skeletal muscle mitochondrial function in persons with COPD: a randomised controlled study
Introduction: Blood-flow restricted training (BFRT) was recently introduced to pulmonary rehabilitation. It remains unknown whether it has the potential to ameliorate the skeletal muscle mitochondrial dysfunction associated with COPD. Aim: We aimed to investigate the effects of BFRT (as low-load strength and sprint training) vs high-load strength training and sprint training (HL) on mitochondrial function in persons with stable COPD. Methods: We randomly assigned participants to 6 weeks lower limb BFRT (strength: 70% occlusion pressure, 30% 1-repetition maximum; sprint: 30s all-out sprints, 70% occlusion pressure during breaks) or HL (strength: 70% 1-repetition maximum; sprint: 30s all-out sprints). Primary outcome was mitochondrial respiratory capacity and H2O2 emission (Oroboros O2k) in permeabilised muscle fibres sampled from vastus lateralis biopsies before and after the intervention. We secondarily investigated maximal voluntary strength. Results: The study is ongoing. To date, 11 participants (69 [67, 72] years, FEV1 61 [49, 70] % pred.) completed the study, 3 dropped out. Mitochondrial complex I + II state 3 respiration changed by -0.20 (−1.08, 1.40) pmol O2/s/mg ww in the BFRT group and by 2.72 (2.27, 3.78) in the HL group. Maximal mitochondrial H2O2 emission changed by -0.08 (−1.62, 0.40) pmol H2O2/s/mg ww in the BFRT group and by 0.25 (−1.43, 0.61) in the HL group. Both groups increased maximal voluntary strength without clinically relevant between-group differences. Conclusions: Six weeks of BFRT may reduce overactivity of mitochondrial complex I + II-linked respiration and maximal H2O2 emission in comparison to HL.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA526
The effect of blood-flow restricted strength and sprint training on skeletal muscle mitochondrial function in persons with COPD: a randomised controlled study
Introduction: Blood-flow restricted training (BFRT) was recently introduced to pulmonary rehabilitation. It remains unknown whether it has the potential to ameliorate the skeletal muscle mitochondrial dysfunction associated with COPD. Aim: We aimed to investigate the effects of BFRT (as low-load strength and sprint training) vs high-load strength training and sprint training (HL) on mitochondrial function in persons with stable COPD. Methods: We randomly assigned participants to 6 weeks lower limb BFRT (strength: 70% occlusion pressure, 30% 1-repetition maximum; sprint: 30s all-out sprints, 70% occlusion pressure during breaks) or HL (strength: 70% 1-repetition maximum; sprint: 30s all-out sprints). Primary outcome was mitochondrial respiratory capacity and H2O2 emission (Oroboros O2k) in permeabilised muscle fibres sampled from vastus lateralis biopsies before and after the intervention. We secondarily investigated maximal voluntary strength. Results: The study is ongoing. To date, 11 participants (69 [67, 72] years, FEV1 61 [49, 70] % pred.) completed the study, 3 dropped out. Mitochondrial complex I + II state 3 respiration changed by -0.20 (−1.08, 1.40) pmol O2/s/mg ww in the BFRT group and by 2.72 (2.27, 3.78) in the HL group. Maximal mitochondrial H2O2 emission changed by -0.08 (−1.62, 0.40) pmol H2O2/s/mg ww in the BFRT group and by 0.25 (−1.43, 0.61) in the HL group. Both groups increased maximal voluntary strength without clinically relevant between-group differences. Conclusions: Six weeks of BFRT may reduce overactivity of mitochondrial complex I + II-linked respiration and maximal H2O2 emission in comparison to HL.
- Open Access
- 15 August 2024
- Published by Springer Nature in BMC Sports Science, Medicine and Rehabilitation
- Vol. 16 (1) , 1-12
Exploring immediate cardiorespiratory responses: low-intensity blood flow restricted cycling vs. moderate-intensity traditional exercise in a randomized crossover trial
Purpose: Blood-flow restriction (BFR) endurance training may increase endurance performance and muscle strength similar to traditional endurance training while requiring a lower training intensity. We aimed to compare acute cardiorespiratory responses to low-intensity interval exercise under BFR with moderate-intensity traditional interval exercise (TRA). Methods: We conducted a randomized crossover study. The protocol involved three cycling intervals interspersed with 1 min resting periods. With a 48-h washout period, individuals performed the protocol twice in random order: once as BFR-50 (i.e., 50% incremental peak power output [IPPO] and 50% limb occlusion pressure [LOP]) and once as TRA-65 (65% IPPO without occlusion). TRA-65 intervals lasted 2 min, and time-matched BFR-50 lasted 2 min and 18 s. Respiratory parameters were collected by breath-by-breath analysis. The ratings of perceived breathing and leg exertion (RPE, 0 to 10) were assessed. Linear mixed models were used for analysis. Results: Out of the 28 participants initially enrolled in the study, 24 healthy individuals (18 males and 6 females) completed both measurements. Compared with TRA-65, BFR-50 elicited lower minute ventilation (VE, primary outcome) (-3.1 l/min [-4.4 to -1.7]), oxygen consumption (-0.22 l/min [-0.28 to -0.16]), carbon dioxide production (-0.25 l/min [-0.29 to -0.20]) and RPE breathing (-0.9 [-1.2 to -0.6]). RPE leg was significantly greater in the BFR-50 group (1.3 [1.0 to 1.7]). Conclusion: BFR endurance exercise at 50% IPPO and 50% LOP resulted in lower cardiorespiratory work and perceived breathing effort compared to TRA at 65% IPPO. BFR-50 could be an attractive alternative for TRA-65, eliciting less respiratory work and perceived breathing effort while augmenting perceived leg muscle effort. Trial registration: NCT05163600; December 20, 2021.
- 15 August 2024
- Published by Springer Nature in BMC Sports Science, Medicine and Rehabilitation
- Vol. 16 (1) , 1-12
Open AccessExploring immediate cardiorespiratory responses: low-intensity blood flow restricted cycling vs. moderate-intensity traditional exercise in a randomized crossover trial
Purpose: Blood-flow restriction (BFR) endurance training may increase endurance performance and muscle strength similar to traditional endurance training while requiring a lower training intensity. We aimed to compare acute cardiorespiratory responses to low-intensity interval exercise under BFR with moderate-intensity traditional interval exercise (TRA). Methods: We conducted a randomized crossover study. The protocol involved three cycling intervals interspersed with 1 min resting periods. With a 48-h washout period, individuals performed the protocol twice in random order: once as BFR-50 (i.e., 50% incremental peak power output [IPPO] and 50% limb occlusion pressure [LOP]) and once as TRA-65 (65% IPPO without occlusion). TRA-65 intervals lasted 2 min, and time-matched BFR-50 lasted 2 min and 18 s. Respiratory parameters were collected by breath-by-breath analysis. The ratings of perceived breathing and leg exertion (RPE, 0 to 10) were assessed. Linear mixed models were used for analysis. Results: Out of the 28 participants initially enrolled in the study, 24 healthy individuals (18 males and 6 females) completed both measurements. Compared with TRA-65, BFR-50 elicited lower minute ventilation (VE, primary outcome) (-3.1 l/min [-4.4 to -1.7]), oxygen consumption (-0.22 l/min [-0.28 to -0.16]), carbon dioxide production (-0.25 l/min [-0.29 to -0.20]) and RPE breathing (-0.9 [-1.2 to -0.6]). RPE leg was significantly greater in the BFR-50 group (1.3 [1.0 to 1.7]). Conclusion: BFR endurance exercise at 50% IPPO and 50% LOP resulted in lower cardiorespiratory work and perceived breathing effort compared to TRA at 65% IPPO. BFR-50 could be an attractive alternative for TRA-65, eliciting less respiratory work and perceived breathing effort while augmenting perceived leg muscle effort. Trial registration: NCT05163600; December 20, 2021.
- Open Access
- 1 March 2024
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 19, 721-730
Automated Quantification of QT-Intervals by an Algorithm: A Validation Study in Patients with Chronic Obstructive Pulmonary Disease
Study Objectives: To assess the diagnostic accuracy of a purpose-designed QTc-scoring algorithm versus the established hand-scoring in patients with chronic obstructive pulmonary disease (COPD) undergoing sleep studies. Methods: We collected 62 overnight electrocardiogram (ECG) recordings in 28 COPD patients. QT-intervals corrected for heart rate (QTc, Bazett) were averaged over 1-min periods and quantified, both by the algorithm and by cursor-assisted hand-scoring. Hand-scoring was done blinded to the algorithm-derived results. Bland-Altman statistics and confusion matrixes for three thresholds (460, 480, and 500ms) were calculated. Results: A total of 32944 1-min periods and corresponding mean QTc-intervals were analysed manually and by computer. Mean difference between manual and algorithm-based QTc-intervals was − 1ms, with limits of agreement of − 18 to 16ms. Overall, 2587 (8%), 357 (1%), and 0 QTc-intervals exceeding the threshold 460, 480, and 500ms, respectively, were identified by hand-scoring. Of these, 2516, 357, and 0 were consistently identified by the algorithm. This resulted in a diagnostic classification accuracy of 0.98 (95% CI 0.98/0.98), 1.00 (1.00/1.00), and 1.00 (1.00/1.00) for 460, 480, and 500ms, respectively. Sensitivity was 0.97, 1.00, and NA for 460, 480, and 500ms, respectively. Specificity was 0.98, 1.00, and 1.00 for 460, 480, and 500ms, respectively. Conclusion: Overall, 8% of nocturnal 1-min periods showed clinically relevant QTc prolongations in patients with stable COPD. The automated QTc-algorithm accurately identified clinically relevant QTc-prolongations with a very high sensitivity and specificity. Using this tool, hospital sleep laboratories may identify asymptomatic patients with QTc-prolongations at risk for malignant arrhythmia, allowing them to consult a cardiologist before an eventual cardiac event.
- 1 March 2024
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 19, 721-730
Open AccessAutomated Quantification of QT-Intervals by an Algorithm: A Validation Study in Patients with Chronic Obstructive Pulmonary Disease
Study Objectives: To assess the diagnostic accuracy of a purpose-designed QTc-scoring algorithm versus the established hand-scoring in patients with chronic obstructive pulmonary disease (COPD) undergoing sleep studies. Methods: We collected 62 overnight electrocardiogram (ECG) recordings in 28 COPD patients. QT-intervals corrected for heart rate (QTc, Bazett) were averaged over 1-min periods and quantified, both by the algorithm and by cursor-assisted hand-scoring. Hand-scoring was done blinded to the algorithm-derived results. Bland-Altman statistics and confusion matrixes for three thresholds (460, 480, and 500ms) were calculated. Results: A total of 32944 1-min periods and corresponding mean QTc-intervals were analysed manually and by computer. Mean difference between manual and algorithm-based QTc-intervals was − 1ms, with limits of agreement of − 18 to 16ms. Overall, 2587 (8%), 357 (1%), and 0 QTc-intervals exceeding the threshold 460, 480, and 500ms, respectively, were identified by hand-scoring. Of these, 2516, 357, and 0 were consistently identified by the algorithm. This resulted in a diagnostic classification accuracy of 0.98 (95% CI 0.98/0.98), 1.00 (1.00/1.00), and 1.00 (1.00/1.00) for 460, 480, and 500ms, respectively. Sensitivity was 0.97, 1.00, and NA for 460, 480, and 500ms, respectively. Specificity was 0.98, 1.00, and 1.00 for 460, 480, and 500ms, respectively. Conclusion: Overall, 8% of nocturnal 1-min periods showed clinically relevant QTc prolongations in patients with stable COPD. The automated QTc-algorithm accurately identified clinically relevant QTc-prolongations with a very high sensitivity and specificity. Using this tool, hospital sleep laboratories may identify asymptomatic patients with QTc-prolongations at risk for malignant arrhythmia, allowing them to consult a cardiologist before an eventual cardiac event.